Louise Provencher

8.5k citations
110 papers · 4.8k indexed · 3 hit papers · h-index 31
Topics
Breast Cancer Treatment Studies (42 papers)HER2/EGFR in Cancer Research (36 papers)Cancer Treatment and Pharmacology (32 papers)

In The Last Decade

Louise Provencher

107 papers receiving 4.7k citations

Hit Papers

Phase III Study of Bevacizumab Plus Docetaxel Compared Wi...2010202620152020201020142014200400600

Peers

Louise Provencher
Comparison fields: 5 of 122
  • Oncology 3.2k
  • Cancer Research 1.8k
  • Pulmonary and Respiratory Medicine 1.1k
  • Molecular Biology 842
  • Pathology and Forensic Medicine 803
Replace Pierre Kerbrat with:
Pierre Kerbrat France
Seigo Nakamura Japan
Nicola S. Russell Netherlands
D. Azria France
Orazio Caffo Italy
Roger von Moos Switzerland
Yazid Belkacémi France
P Sismondi Italy
Enzo Galligioni Italy
Michael P. Lux Germany
Louise Provencher relative to Pierre Kerbrat France Pierre Kerbrat's profile →
Citations per field
00.5×1.5×
Pierre Kerbrat · 1×
Citations per year

Countries citing papers authored by Louise Provencher

Since Specialization
Citations

This map shows the geographic impact of Louise Provencher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Provencher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Provencher more than expected).

Fields of papers citing papers by Louise Provencher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Provencher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Provencher. The network helps show where Louise Provencher may publish in the future.

Co-authorship network of co-authors of Louise Provencher

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Provencher. A scholar is included among the top collaborators of Louise Provencher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Provencher. Louise Provencher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 5
4 279
5 14
6 6
7 3
8
Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.
59
9 19
10 31
11 21
12 33
13 58
14 23
15 41
16 268
17 41
18
Textes furtifs : Autour de la sculpture (1978-1999)
0
19 46
20 14

About Louise Provencher

Louise Provencher is a scholar working on Cancer Research, Oncology and Family Practice, having authored 110 papers that have together received 4.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (42 papers), HER2/EGFR in Cancer Research (36 papers) and Cancer Treatment and Pharmacology (32 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (3.2k citations) and Pathology and Forensic Medicine (803 citations). Louise Provencher has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Elizabeth Maunsell, Julie Lemieux, André Robidoux, Arlene Chan, Gilles Romieu, Xavier Pivot, Piotr Tomczak, Luc Dirix, Brigitte Poirier and Caroline Diorio. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026